Zebra Technologies
ZBRA
$284.40
+7.49%
Zebra Technologies is the largest provider of automatic identification and data capture technology to enterprises, offering barcode printers and scanners, mobile computers, and workflow optimization software primarily for retail, transportation logistics, manufacturing, and healthcare markets. As a market leader in its niche, the company distinguishes itself through its comprehensive hardware-software solutions that improve operational efficiency. The current investor narrative centers on a growth acceleration story, driven by a 14.3% YoY revenue increase in Q1 2026 and bullish guidance that exceeded analyst expectations, though margin compression and a 22% year-over-year stock decline keep debates alive about sustainability.…
ZBRA
Zebra Technologies
$284.40
Related headlines
Investment Opinion: Should I buy ZBRA Today?
Rating: Buy. Zebra Technologies is a compelling growth-at-a-reasonable-price (GARP) opportunity, with accelerating revenue growth, a forward PE of 12.5x, and 28.2% upside to the average analyst target of $333.18. The consensus Buy rating from 17 analysts supports this view.
Supporting Evidence: Revenue grew 14.3% YoY in Q1 2026, accelerating from sub-2% growth in prior quarters. The forward PE of 12.5x is a steep discount to the trailing PE of 29.5x and the industry average, implying significant earnings growth ahead. Free cash flow of $836M TTM provides a solid cash generation base. The PS ratio of 2.3x is below the industry average, suggesting the stock is not overvalued on sales. Analyst targets range from $292.02 (12.4% upside) to $400 (53.9% upside), indicating strong conviction.
Risks & Conditions: The primary risk is that margin compression persists, preventing earnings growth from materializing. If net margins fail to expand above 10%, the forward PE could prove too optimistic. A second risk is macro headwinds compressing the multiple further. This Buy rating would be downgraded to Hold if revenue growth decelerates below 10% or if the stock approaches the analyst average target without margin improvement. It would be upgraded if gross margins exceed 50% and operating margins exceed 15%. Overall, Zebra appears undervalued relative to its growth trajectory and analyst expectations.
Sign up to view all
ZBRA 12-Month Price Forecast
Zebra Technologies is positioned for a strong recovery, with accelerating revenue growth and a valuation that does not fully reflect the earnings rebound expected by analysts. The forward PE of 12.5x is attractive relative to history and peers, and the consensus Buy rating with 28.2% upside provides a favorable risk/reward. However, margin compression and macro uncertainty warrant caution. The stance would be upgraded to high confidence if gross margins exceed 50% and operating margins improve in Q2 2026. It would be downgraded to neutral if revenue growth decelerates below 10% or if the stock fails to hold above $240 support.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Zebra Technologies's 12-month outlook, with a consensus price target around $332.44 and implied upside of +16.9% versus the current price.
Average Target
$332.44
0 analysts
Implied Upside
+16.9%
vs. current price
Analyst Count
—
covering this stock
Price Range
$292 - $400
Analyst target range
Zebra Technologies is covered by 17 analysts, with a consensus recommendation of 'Buy' (mean rating 1.67 on a 1-5 scale). The average target price is $333.18, implying 28.2% upside from the current price of $259.92. The distribution leans bullish, with recent ratings from Barclays (Overweight), Needham (Buy), and Baird (Outperform) reinforcing positive sentiment, while Citigroup and Truist maintain Neutral/Hold ratings. The target range spans from a low of $292.02 to a high of $400.00, representing a spread of 37% from low to high, indicating moderate uncertainty. The high target of $400 assumes a full recovery to 52-week highs and beyond, likely driven by sustained growth acceleration and margin expansion. The low target of $292.02 still implies 12.4% upside, suggesting even the most bearish analyst sees value. Recent rating actions have been stable, with no downgrades in the past two months, and the consensus has held at Buy. The wide spread reflects the debate around whether the growth rebound is sustainable, but the overall bullish consensus supports a positive outlook.
Drowning in data?
Find the real signal!
Bulls vs Bears: ZBRA Investment Factors
Zebra Technologies presents a compelling turnaround story with accelerating revenue growth, strong free cash flow, and a consensus Buy rating from analysts. The stock offers significant upside potential, with an average target price implying 28.2% gains and a forward PE of 12.5x that appears undervalued relative to history and peers. However, margin compression, elevated debt, and a high beta introduce notable risks. The single most important tension is whether the revenue acceleration can translate into earnings growth—if margins stabilize and EPS expands, the stock could re-rate significantly; if not, the current valuation may prove justified. Overall, the bull case currently has stronger evidence given the growth trajectory and analyst support, but investors must monitor margin trends closely.
Bullish
- Revenue Growth Accelerating: Q1 2026 revenue grew 14.3% YoY to $1.495B, accelerating sharply from 1.7% in Q4 2025 and 2.1% in Q3 2025, signaling a strong demand recovery in enterprise digitization and supply chain modernization.
- Significant Analyst Upside: The average analyst target of $333.18 implies 28.2% upside from the current price of $259.92, with a consensus Buy rating (1.67 on a 1-5 scale) and a high target of $400 suggesting potential for substantial gains.
- Attractive Forward Valuation: The forward PE of 12.5x is well below the trailing PE of 29.5x and the historical average, indicating the market expects a sharp earnings recovery. The PS ratio of 2.3x is also below the industry average, suggesting the stock is not overvalued on a sales basis.
- Strong Free Cash Flow Generation: Trailing twelve-month free cash flow is $836M, with Q1 2026 FCF of $163M up from $158M a year ago. This provides financial flexibility for investments, debt reduction, or share repurchases ($300M in Q1 alone).
Bearish
- Margin Compression Persists: Net margin declined to 9.0% in Q1 2026 from 10.4% a year ago, and operating margin fell to 14.4% from 14.9%. Despite revenue growth, rising operating expenses are squeezing profitability.
- High Debt and Tight Liquidity: Debt-to-equity is 0.78, and the current ratio of 0.97 indicates current liabilities exceed current assets. The company spent $300M on buybacks in Q1, which could strain cash if growth slows.
- Stock Still Down 22% Over One Year: Despite recent gains, the stock is down 22% over the past year and trades at 43.5% of its 52-week range. The 52-week low of $199.05 is 23.4% below the current price, highlighting downside risk.
- High Beta Amplifies Market Risk: With a beta of 1.605, the stock is 60.5% more volatile than the market. In a downturn, this could lead to outsized losses, especially if macro conditions worsen.
ZBRA Technical Analysis
Zebra Technologies is in a recovery phase from a significant downtrend, with the stock down 22% over the past year but up 14.1% in the last three months. The current price of $259.92 sits at 43.5% of its 52-week range ($199.05–$352.66), indicating it has recovered from the lows but remains well below the highs. This positioning suggests the stock is in a rebuilding phase, with potential for further upside if momentum continues, but still carries the weight of past losses. Short-term momentum is accelerating, with a 1-month gain of 4.9% and a 3-month gain of 14.1%, contrasting sharply with the 1-year decline of 22%. This divergence signals a potential trend reversal, as the stock has broken its downtrend and is now forming higher lows. The relative strength versus the S&P 500 is positive over 1-month and 3-month periods, confirming that recent outperformance is not just a market-wide effect. Key support lies at the 52-week low of $199.05, while resistance is at the 52-week high of $352.66. A breakout above $352.66 would signal a full reversal of the downtrend and a return to all-time highs, while a breakdown below $199.05 could indicate renewed selling pressure. With a beta of 1.605, the stock is 60.5% more volatile than the market, meaning it amplifies market moves and requires careful risk management.
Beta
1.60
1.60x market volatility
Max Drawdown
-41.6%
Largest decline past year
52-Week Range
$199-$353
Price range past year
Annual Return
-15.0%
Cumulative gain past year
| Period | ZBRA Return | S&P 500 |
|---|---|---|
| 1m | +13.1% | +1.6% |
| 3m | +31.9% | +4.1% |
| 6m | +19.5% | +6.8% |
| 1y | -15.0% | +16.3% |
| ytd | +14.5% | +8.6% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
ZBRA Fundamental Analysis
Zebra Technologies is experiencing a revenue growth resurgence, with Q1 2026 revenue of $1.495 billion representing a 14.3% YoY increase, accelerating from the 1.7% growth in Q4 2025 and the 2.1% growth in Q3 2025. The Enterprise Visibility and Mobility (EVM) segment contributed $865 million and Asset Intelligence & Tracking (AIT) added $455 million, showing broad-based demand. This acceleration suggests the company is benefiting from enterprise digitization and supply chain modernization trends, supporting a positive investment case. Profitability is solid but showing margin compression. Net income for Q1 2026 was $135 million, up from $136 million in Q1 2025, but net margin declined to 9.0% from 10.4% a year ago. Gross margin improved to 49.6% from 49.3% in Q1 2025, but operating margin fell to 14.4% from 14.9%, reflecting higher operating expenses. The company remains profitable with a trailing PE of 29.5x, but margin trends warrant monitoring. The balance sheet is healthy but leveraged. Debt-to-equity stands at 0.78, and free cash flow for Q1 2026 was $163 million, up from $158 million in Q1 2025, with trailing twelve-month FCF of $836 million. The company generated $176 million in operating cash flow in Q1, sufficient to cover capex of $13 million, and has $114 million in cash. However, the current ratio of 0.97 indicates tight liquidity, and the company used $300 million for stock repurchases in Q1, which could strain cash if growth slows.
Quarterly Revenue
$1.5B
2026-04
Revenue YoY Growth
+14.3%
YoY Comparison
Gross Margin
49.6%
Latest Quarter
Free Cash Flow
$836000000.0B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is ZBRA Overvalued?
Since net income is positive ($135 million), the primary valuation metric is the PE ratio. The trailing PE is 29.5x, while the forward PE is 12.5x, implying the market expects significant earnings growth in the coming year. The wide gap between trailing and forward PE suggests that analysts anticipate a sharp earnings recovery, which is consistent with the recent revenue acceleration. Compared to the industry average (Communication Equipment), Zebra's trailing PE of 29.5x is at a premium, but the forward PE of 12.5x is much lower, indicating that the market is pricing in a strong earnings rebound. The PS ratio of 2.3x is below the industry average, suggesting the stock is not overvalued on a sales basis. Historically, Zebra's trailing PE has ranged from about 18x to 207x over the past five years. The current 29.5x is near the lower end of that range, which could indicate a value opportunity if the earnings recovery materializes. However, the historical high of 207x in Q4 2023 was due to depressed earnings, so the current multiple is more reasonable. The forward PE of 12.5x is well below the historical average, suggesting the stock is undervalued relative to its own history if earnings meet expectations.
PE
29.5x
Latest Quarter
vs. Historical
Mid-Range
5-Year PE Range 18x~44x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
17.6x
Enterprise Value Multiple
Investment Risk Disclosure
Financial & Operational Risks: Zebra's net margin declined from 10.4% to 9.0% YoY in Q1 2026, and operating margin fell from 14.9% to 14.4%, indicating that revenue growth is not flowing through to the bottom line. The company carries $0.78 debt-to-equity and a current ratio of 0.97, meaning short-term obligations exceed liquid assets. Heavy share repurchases of $300M in Q1 could strain cash if growth decelerates. Free cash flow of $836M TTM is healthy, but any disruption in cash generation could pressure the balance sheet.
Market & Competitive Risks: With a beta of 1.605, Zebra is highly sensitive to market movements. The stock is down 22% over the past year, reflecting sector rotation away from growth stocks amid rising interest rates. The Communication Equipment industry faces competitive pressure from larger tech players and potential commoditization of hardware. Recent news about stubborn inflation taking rate cuts off the table could further compress growth stock multiples. The stock's 52-week range of $199.05–$352.66 shows significant volatility.
Worst-Case Scenario: If revenue growth stalls due to macro headwinds or competitive pressures, and margins continue to compress, the stock could retest its 52-week low of $199.05. This would represent a 23.4% decline from the current price of $259.92. In a severe recession, the stock could fall further, potentially to $180 (based on historical max drawdown of -41.6% from the 52-week high of $352.66), implying a 30.8% loss. The high short ratio of 3.77 days to cover could amplify downside if negative news triggers a selloff.
FAQ
The key risks are: 1) Margin compression – net margin declined from 10.4% to 9.0% YoY, and operating margin fell to 14.4%, which could persist if cost pressures continue. 2) High leverage – debt-to-equity of 0.78 and current ratio of 0.97 indicate tight liquidity, and heavy buybacks ($300M in Q1) could strain cash. 3) Macro sensitivity – with a beta of 1.605, the stock is highly volatile and could fall sharply in a market downturn. 4) Execution risk – the forward PE of 12.5x relies on earnings growth that has not yet materialized; any disappointment could lead to multiple compression.
The 12-month forecast is positive, with a base case target range of $290–$340 (45% probability), aligning with the average analyst target of $333.18. The bull case (30% probability) targets $350–$400, driven by sustained growth and margin expansion. The bear case (25% probability) sees the stock falling to $200–$250 if growth disappoints. The most likely scenario is the base case, where revenue growth moderates to 10-12% and margins stabilize, leading to gradual appreciation. Key catalysts include the next earnings report and margin trends.
ZBRA appears undervalued based on forward metrics. The forward PE of 12.5x is well below the trailing PE of 29.5x and the historical average of around 20x, implying the market expects a sharp earnings rebound. The PS ratio of 2.3x is below the industry average, suggesting the stock is not overvalued on sales. Compared to its own history, the current trailing PE of 29.5x is near the lower end of its five-year range (18x–207x), indicating a potential value opportunity. The market is pricing in a strong recovery, and if earnings materialize as expected, the stock is undervalued.
ZBRA appears to be a good buy for investors with a medium-to-long-term horizon, given the accelerating revenue growth (14.3% YoY), attractive forward PE of 12.5x, and 28.2% upside to the average analyst target of $333.18. The consensus Buy rating from 17 analysts supports this view. However, the stock carries risks including margin compression (net margin fell to 9.0% from 10.4%) and high volatility (beta 1.605). It is best suited for those who can tolerate short-term fluctuations and are confident in the earnings recovery narrative. For conservative investors, waiting for confirmation of margin stabilization may be prudent.
ZBRA is better suited for long-term investment (12+ months) given its growth trajectory and attractive forward valuation. The stock is in a recovery phase with accelerating revenue growth, but it has high volatility (beta 1.605) and a 22% one-year decline, making it risky for short-term trading. The lack of a dividend means returns depend entirely on price appreciation. A minimum holding period of 12 months is recommended to allow the earnings recovery to materialize. Short-term traders could capitalize on momentum, but the high beta and short ratio of 3.77 days increase risk.
